Full Answer
Encounter for antibody response examination Z01.84 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z01.84 became effective on October 1, 2020. This is the American ICD-10-CM version of Z01.84 - other ...
Abnormal immunological finding in serum, unspecified. R76.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM R76.9 became effective on October 1, 2019. This is the American ICD-10-CM version of R76.9 - other international versions of ICD-10 R76.9 may differ.
Other specified anemias. D64.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM D64.89 became effective on October 1, 2019. This is the American ICD-10-CM version of D64.89 - other international versions of ICD-10 D64.89 may differ.
Z01.84 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z01.84 became effective on October 1, 2020. This is the American ICD-10-CM version of Z01.84 - other international versions of ICD-10 Z01.84 may differ. A type 1 excludes note is a pure excludes.
R76. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R76. 0 became effective on October 1, 2021.
R77. 9 - Abnormality of plasma protein, unspecified. ICD-10-CM.
Abnormality of plasma protein, unspecified The 2022 edition of ICD-10-CM R77. 9 became effective on October 1, 2021. This is the American ICD-10-CM version of R77.
There are three codes for COVID-19 testing: 87635 is designed to detect the COVID-19 virus and effective March 13, 2020, and 86328 and 86769 will be used to identify the presence of antibodies to the COVID-19 virus and are effective April 10, 2020.
Protein Electrophoresis Analyzer, SerumTest NameCPT CodesProtein Electrophoresis84165Total Protein84155Pathologist Interpretation84165-26Possible Additional Testing6 more rows
001487: Protein Electrophoresis, Serum | Labcorp.
Serum immunofixation. The immunofixation blood test is used to identify proteins called immunoglobulins in blood. Too much of the same immunoglobulin is usually due to different types of blood cancer. Immunoglobulins are antibodies that help your body fight infection.
The MUEs for CPT code 86334 (Immunofixation electrophoresis) is changed from 1 to 2 units of service to allow multiple electrophoresis or immunofixation tests to be performed on the same specimen when monitoring multiple myeloma patients.
Serum protein electrophoresis (SPEP) is a laboratory technique that's used to determine the levels of some types of proteins in a blood sample. There are a number of reasons why a doctor may order this test.
87426 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])
For individuals with MIS and COVID-19, assign code U07. 1, COVID-19, as the principal/first-listed diagnosis and assign code M35. 81 as an additional diagnosis. If MIS develops as a result of a previous COVID-19 infection, assign codes M35.
86769 — Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]). Code 86328 should be used for antibody tests with a single-step method immunoassay — typically a strip with all the necessary components for the assay, appropriate for a point-of-care testing platform.
Quantitation of serum immunoglobulins IgA, IgG, and IgM; IFE qualitative interpretation of heavy- and light-chain patterns; serum protein electrophoresis; quantitation of serum free κ and λ light chains plus κ:λ ratio
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Sample should be allowed to clot and the serum separated as soon as possible to prevent hemolysis.
Electrophoresis followed by immunodiffusion against monospecific antisera to immunoglobulin and individual heavy and light chains (IFE); protein electrophoresis on agarose media; turbidimetric quantitation of IgA, IgG, and IgM; turbidimetric quantitation of free κ and λ light chains
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) recommend the use of serum free light chain assays in the initial diagnostic work-up of multiple myeloma and related disorders.
1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Multiple Myeloma, Version 1.2011. Fort Washington, Pa: NCCN; 2011.